Supernus Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,964 | 0.0% | 59,632 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,089 | 0.0% | 64,642 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,405 | 0.0% | 76,288 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 2,498 | 0.0% | 76,288 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 2,883 | 0.0% | 79,736 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 2,486 | 0.0% | 79,736 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 375 | 0.0% | 14,023 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 1,781 | 0.0% | 49,160 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 406 | 0.0% | 14,023 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 387 | 0.0% | 14,023 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,380 | 0.0% | 45,900 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 1,781 | 0.0% | 49,160 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 2,369 | 0.0% | 66,420 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 2,517 | 0.0% | 74,370 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 782 | 0.0% | 27,038 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 2,835 | 0.0% | 87,722 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 2,852 | 0.0% | 97,789 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 2,501 | 0.0% | 93,792 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 2,888 | 0.0% | 93,792 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 2,572 | 0.0% | 98,252 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 2,310 | 0.0% | 91,812 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,079 | 0.0% | 51,771 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 926 | 0.0% | 39,002 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 462 | 0.0% | 25,706 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 1,663 | 0.0% | 70,106 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 211 | 0.0% | 19,312 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 139 | 0.0% | 15,513 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 117 | 0.0% | 15,513 | 12/31/2013 |